首页> 外国专利> Method of determining the level of ercc1 gene expression and use of chemotherapeutic regimen selected by a method in the preparation of a medicament

Method of determining the level of ercc1 gene expression and use of chemotherapeutic regimen selected by a method in the preparation of a medicament

机译:确定ercc1基因表达水平的方法以及通过药物制备方法选择的化疗方案的使用

摘要

The present invention relates to prognostic methods which are useful in medicine, particularly cancer chemotherapy. The object of the invention to provide a method for assessing ERCC1 expression levels in fixed or fixed and paraffin embedded tissues and determine a platinum-based chemotherapy by examination of the amount of ERCC1 mRNA in a patient's tumor cells and comparing it to a predetermined threshold expression level. More specifically, the invention provides to oligonucleotide primer pair ERCC1 and methods comprising their use for detecting levels of ERCC1 mRNA.
机译:本发明涉及可用于医学特别是癌症化学疗法的预后方法。本发明的目的是提供一种方法,用于评估固定的或固定的和石蜡包埋的组织中的ERCC1表达水平,并通过检查患者肿瘤细胞中ERCC1 mRNA的量并将其与预定的阈值表达进行比较来确定基于铂的化学疗法。水平。更具体地,本发明提供了寡核苷酸引物对ERCC1和包括其用于检测ERCC1 mRNA水平的方法。

著录项

  • 公开/公告号IL156272A

    专利类型

  • 公开/公告日2013-12-31

    原文格式PDF

  • 申请/专利权人 RESPONSE GENETICS INC.;

    申请/专利号IL20030156272

  • 发明设计人

    申请日2003-06-02

  • 分类号C12N;G01N33/50;A61K31/7068;A61K33/24;A61P35;C12N15/09;C12Q;C12Q1/68;G01N;G01N33/574;

  • 国家 IL

  • 入库时间 2022-08-21 15:57:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号